PAR-1-dependent and PAR-independent pro-inflammatory signaling in human lung fibroblasts exposed to thrombin
Author:
Publisher
Wiley
Subject
Cell Biology,Clinical Biochemistry,Physiology
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1002/jcp.24061/fullpdf
Reference51 articles.
1. Administration of a potent antagonist of protease-activated receptor-1 (PAR-1) attenuates vascular Restenosis following balloon angioplasty in rats;Andrade-Gordon;J Pharmacol Exp Ther,2001
2. Factor Xa stimulates fibroblast procollagen production, proliferation, and calcium signaling via PAR1 activation;Blanc-Brude;Exp Cell Res,2005
3. Thrombin differentiates normal lung fibroblasts to a myofibroblast phenotype via the proteolytically activated receptor-1 and a protein kinase C-dependent pathway;Bogatkevich;J Biol Chem,2001
4. Molecular cloning, expression and potential functions of the human proteinase-activated receptor-2;Bohm;Biochem J,1996
5. A role for CXCL12 (SDF-1alpha) in the pathogenesis of multiple sclerosis: Regulation of CXCL12 expression in astrocytes by soluble myelin basic protein;Calderon;J Neuroimmunol,2006
Cited by 29 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Impact of Fibrinogen, Fibrin Thrombi, and Thrombin on Cancer Cell Extravasation Using In Vitro Microvascular Networks;Advanced Healthcare Materials;2023-05-12
2. The Yin‐Yang roles of protease‐activated receptors in inflammatory signalling and diseases;The FEBS Journal;2022-03-03
3. Baicalin Alleviates Thrombin-Induced Inflammation in Vascular Smooth Muscle Cells;BioMed Research International;2022-01-21
4. Dabigatran ameliorates airway smooth muscle remodeling in asthma by modulating Yes‐associated protein;Journal of Cellular and Molecular Medicine;2020-06-15
5. Thrombin induces protease-activated receptor 1 signaling and activation of human atrial fibroblasts and dabigatran prevents these effects;International Journal of Cardiology;2018-11
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3